Daniel Delubac

Scientific Advisory Board at Alix Ventures

Raleigh-Durham-Chapel Hill Area

About

Daniel Delubac is an engineer and operator focused on biotechnology, with experience in clinical diagnostics research, product development, lab operations, and synthetic biology. He began his career at Counsyl building an automated system for clinical-grade Next Generation Sequencing, then worked on process engineering and automation at Guardant Health, and led wetlab R&D, process engineering, automation, and lab operations at Freenome. He currently serves as COO of Xilis, working on cancer care using micro-organoids, and holds a B.S. and M.S. in Applied Physics from France and a Ph.D. in biomedical engineering from Carnegie Mellon University.

LinkedIn ↗

Invests in

Biotech

Experience

IORGANBIOChief Executive Officercurrent2025 — presentRaleigh-Durham-Chapel Hill Area
Daniel DelubacVarious positions and experiencescurrent2018 — present
Chemify LimitedPresident, Chief Operating Officer, and Chief Technology Officer2023 — 2024Glasgow, Scotland, United Kingdom
XilisChief Operating Officer and Chief Technology Officer2020 — 2023Raleigh-Durham-Chapel Hill Area
FreenomeVP, Laboratory Technologies and Operations2017 — 2019San Francisco Bay Area
Guardant HealthHead of Process Engineering / Lab Automation2015 — 2017Redwood City
CounsylEngineering Lead - Automation2012 — 2015South San Francisco
Carnegie Mellon UniversityPh.D. Candidate2008 — 2012
Carnegie Mellon UniversityVP2009 — 2010

Education

Carnegie Mellon UniversityDoctor of Philosophy (Ph.D.), Bioengineering and Biomedical Engineering2008 — 2011
Institut national des Sciences appliquées de Rennes2002 — 2006